SCHEDULE 13D/AAccepted Aug 17, 5:30 PM ET
BridgeBio Pharma, Inc. SCHEDULE 13D/A
Accepted (ET)
5:30 PM
Aug 17, 2026
Filed
Aug 17, 2026
Documents
2
Size
32.3 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.